OriGene Logo

Customer Login

Checkout as a new customer

Creating an account has many benefits:

  • See order and shipping status
  • Track order history
  • Check out faster
Create an Account

TissueScan, Pancreatic Cancer cDNA Array I

Be the first to review this product
SKU
PNRT301
TissueScan Pancreatic Cancer Panel I, containing five identical sets of 23 tissues covering four disease stages and normal tissues
  $1,240.00
In Stock*

Frequently Bought Together (4)

D11-18 Polink-1 HRP Polymer Detection for MOUSE and RABBIT antibodies on human tissue
18 ml
$420.00
D12-6 Polink-1 HRP Polymer Detection for MOUSE antibody on human or animal tissue (non-rodent)
6 ml
$250.00
HP205798 qSTAR qPCR primer pairs against Homo sapiens gene GAPDH 200 reactions
$150.00
MP205604 qSTAR qPCR primer pairs against Mus musculus gene Gapdh 200 reactions
$150.00
Specifications
Specifications
Product Data
TissueScan Type Cancer Specific
Array Name Pancreatic Cancer cDNA Array I
Clinical Info
Diagnosis Category Pancreatic Cancer
Tissue Pancreas
Shipping Ambient
Description TissueScan Pancreatic Cancer Panel I, containing five identical sets of 23 tissues covering four disease stages and normal tissues
Reviews
Write Review
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice
Dandawate, Kaushik, Ghosh et al
Gastroenterology (2019)
AI Summary: OriGene products contributed to this study by providing PRLR shRNA (OriGene, #TL313482) and PRLR CRISPR/Cas9 knockout plasmids (OriGene, #KN313482), which were used to knock down or knockout PRLR expression in pancreatic cancer cell lines to investigate the role of prolactin receptor signaling in tumor growth and response to antipsychotic drugs.
Snippet: (Figure 1F and Supplementary Figure 1F-K). Interrogation of the TCGA database also demonstrated higher levels of PRLR mRNA in pancreatic cancers (Supplementary Figure 1L). The high level of PRLR expression was observed early in the tumorigenesis process
Loss of SOD3 (EcSOD) expression promotes an aggressive phenotype in human pancreatic ductal adenocarcinoma
O'Leary, Fath, Bellizzi et al
Clin. Cancer Res. (2015)
AI Summary: OriGene’s TissueScan™ Real-Time PDA qPCR Panel (catalog # PNRT301) was used to examine EcSOD expression levels in normal and pancreatic ductal adenocarcinoma (PDA) human tissue samples, contributing to the study’s analysis of EcSOD’s prognostic significance.
Snippet: EcSOD expression in human normal and PDA samples was examined using a TissueScan TM Real-Time PDA qPCR Panel (I) from ORIGENE Technologies (#PNRT301) and from tissue specimens obtained from patients with PDA at the University of Iowa. ... Cite SaveSaving
Targeting Inhibitors of the Tumor Suppressor PP2A for the Treatment of Pancreatic Cancer
Farrell, Allen-Petersen, Daniel et al
Mol. Cancer Res. (2014)
AI Summary: OriGene's TissueScan Pancreatic Cancer qPCR Panel 1 (PNRT301) was used to analyze gene expression in normal and cancerous human pancreatic tissue samples, helping to demonstrate the overexpression of PP2A inhibitors SET and CIP2A in pancreatic cancer.
Snippet: carried out using the TissueScan Pancreatic Cancer qPCR Panel 1 (PNRT301) array (Origene) which contains dried cDNAs from 23 human pancreas samples including 4 normal and 19 cancer samples in five identical replicate plates. Individual plate runs ... Cite SaveSaving
Showing 1-3 of 3 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products